Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-18), Sectra AB's 5-Day RSI is 25.35.
The industry rank for Sectra AB's 5-Day RSI or its related term are showing as below:
OSTO:SECT B's 5-Day RSI is ranked better than 80.6% of 866
companies
in the Medical Devices & Instruments industry
Industry Median: 50.865
vs OSTO:SECT B: 25.35
Sectra AB (OSTO:SECT B) 5-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Sectra AB 5-Day RSI Related Terms
OSTO:SECT B vs ABT, SYK, MDT: 5-Day RSI Comparison
For the Medical Devices subindustry, Sectra AB's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB 5-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's 5-Day RSI distribution charts can be found below:
* The bar in red indicates where Sectra AB's 5-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sectra AB (OSTO:SECT B) has a 5-Day RSI of 25.35 as of Jul. 18, 2026. According to the industry distribution chart, Sectra AB ranks #168 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 19.4%.
Is Sectra AB's 5-Day RSI too high?
Sectra AB's current 5-Day RSI is 25.35. The Medical Devices & Instruments industry median 5-Day RSI is 50.87. Sectra AB's value of 25.35 is 50.2% below this industry median. Based on the distribution chart, Sectra AB ranks #168 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sectra AB has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's 5-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #168 out of 866 companies for 5-Day RSI. This places Sectra AB in the top 19% of its industry — outperforming the majority of peers. The industry median 5-Day RSI is 50.87. Sectra AB's value of 25.35 is 50.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Medical Devices & Instruments company?
The median 5-Day RSI among Medical Devices & Instruments companies is 50.87, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current 5-Day RSI of 25.35 is 50.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median 5-Day RSI is 50.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current 5-Day RSI is 25.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (OSTO:SECT B) is currently considered Fairly Valued. The stock's GF Value™ is kr295.20, compared to a current price of kr275.20 — trading 6.8% below its estimated fair value. The current 5-Day RSI is 25.35 and 50.2% below the Medical Devices & Instruments industry median of 50.87. Sectra AB's overall GF Score™ is 92/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For Sectra AB (OSTO:SECT B), the current 5-Day RSI is 25.35 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (OSTO:SECT B) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of kr275.20 is trading 6.8% below its estimated GF Value™ of kr295.20.
GuruFocus considers Sectra AB to be Fairly Valued.
Key valuation signals for OSTO:SECT B:
5-Day RSI: 25.35
GF Value™: kr295.20 vs. price of kr275.20 (6.8% below fair value)
Industry Position: 50.2% below the Medical Devices & Instruments median (#168 of 866)
No single metric tells the full story. See the OSTO:SECT B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
92GF Score
Get the complete analysis for OSTO:SECT B
5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SECT B has been successfully added to your 
